{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:09:05Z","timestamp":1784740145845,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,2,14]],"date-time":"2018-02-14T00:00:00Z","timestamp":1518566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,2,14]],"date-time":"2018-02-14T00:00:00Z","timestamp":1518566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>G-protein-coupled receptor (GPCR)-related proteins are dysregulated and the GPCR CC-chemokine receptor 10 (CCR10) is significantly upregulated in inflammation-driven HCC. However, CCR10\u2032s role in inflammation-driven hepatocarcinogenesis remains unknown. The aim of this study was to evaluate the role of CCR10 in inflammation-driven hepatocarcinogenesis. Via a targeted gene expression microarray screening alterations in GPCR family gene expression, we found CCR10 to be significantly upregulated in hepatocytes isolated from inflammation-driven human HCC tumors and matching paracancerous tissues. Tetrachloromethane (CCl4)-induced and diethylnitrosamine (DEN)-induced murine models of inflammatory hepatocarcinogenesis displayed significant hepatocellular TNF and CCR10 upregulation. Exogenous TNF applied to HepG2 and LO2 cell lines as well as wild-type (WT) mice significantly upregulated hepatocellular CCR10 expression, Akt phosphorylation, PCNA expression, and hepatocellular proliferation. Additionally, exogenous TNF significantly upregulated secretion of the natural CCR10 ligand-agonist CCL28 from both cell lines. Transgenic CCR10-knockout (CCR10 KO) in DEN-treated mice significantly increased hepatocellular apoptosis levels and significantly lowered compensatory hepatocellular proliferation but did not affect upstream TNF expression. In addition, DEN-treated CCR10 KO mice showed a significantly lower liver weight\/body weight ratio, significantly lower liver tumor incidence, and significantly smaller tumors. Moreover, exogenous CCR10 expression significantly raised xenograft tumor growth in Balb\/c nude mice. In vitro, CCR10 transfection or CCL28 treatment in HepG2 and LO2 cell lines significantly increased Akt phosphorylation, PCNA expression, and cell proliferation, while CCR10 silencing or Akt inhibition produced the opposite effects. In vivo, hepatocytes isolated from HCC tumor tissue and matching paracancerous tissue in DEN-treated CCR10 KO mice showed significantly lower Akt phosphorylation and PCNA expression relative to WT hepatocytes. In conclusion, inflammation-induced TNF promotes hepatocellular CCR10 expression and downstream PI3K\/Akt-mediated hepatocarcinogenesis. CCR10 appears to function as a linkage between TNF stimulation and downstream PI3K\/Akt pathway activation and shows promise as a potential therapeutic target for inflammation-driven HCC.<\/jats:p>","DOI":"10.1038\/s41419-018-0267-9","type":"journal-article","created":{"date-parts":[[2018,2,14]],"date-time":"2018-02-14T12:34:27Z","timestamp":1518611667000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K\/Akt pathway activation"],"prefix":"10.1038","volume":"9","author":[{"given":"Qiong","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-xian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-li","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-zhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu-hua","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-feng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,14]]},"reference":[{"key":"267_CR1","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1586\/17474124.2015.1028363","volume":"9","author":"MC Wallace","year":"2015","unstructured":"Wallace, M. C., Preen, D., Jeffrey, G. P. & Adams, L. A. The evolving epidemiology of hepatocellular carcinoma: a global perspective. Expert Rev. Gastroenterol. Hepatol. 9, 765\u2013779 (2015).","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"267_CR2","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.3892\/ijo.2013.1829","volume":"42","author":"H Shiraha","year":"2013","unstructured":"Shiraha, H., Yamamoto, K. & Namba, M. Human hepatocyte carcinogenesis (review). Int. J. Oncol. 42, 1133\u20131138 (2013).","journal-title":"Int. J. Oncol."},{"key":"267_CR3","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s11684-013-0256-4","volume":"7","author":"B Sun","year":"2013","unstructured":"Sun, B. & Karin, M. Inflammation and liver tumorigenesis. Front. Med. 7, 242\u2013254 (2013).","journal-title":"Front. Med."},{"key":"267_CR4","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1016\/j.cellsig.2013.07.022","volume":"25","author":"F Okajima","year":"2013","unstructured":"Okajima, F. Regulation of inflammation by extracellular acidification and proton-sensing GPCRs. Cell. Signal. 25, 2263\u20132271 (2013).","journal-title":"Cell. Signal."},{"key":"267_CR5","first-page":"37","volume":"9","author":"J Wu","year":"2012","unstructured":"Wu, J., Xie, N., Zhao, X., Nice, E. C. & Huang, C. Dissection of aberrant GPCR signaling in tumorigenesis\u2013a systems biology approach. Cancer Genom. Proteom. 9, 37\u201350 (2012).","journal-title":"Cancer Genom. Proteom."},{"key":"267_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8369","volume":"6","author":"Y Yang","year":"2015","unstructured":"Yang, Y. et al. [beta]-Arrestin1 enhances hepatocellular carcinogenesis through inflammation-mediated Akt signalling. Nat. Commun. 6, 7369 (2015).","journal-title":"Nat. Commun."},{"key":"267_CR7","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani, A., Allavena, P., Sica, A. & Balkwill, F. Cancer-related inflammation. Nature 454, 436\u2013444 (2008).","journal-title":"Nature"},{"key":"267_CR8","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/ni1433","volume":"8","author":"H Sigmundsdottir","year":"2007","unstructured":"Sigmundsdottir, H. et al. DCs metabolize sunlight-induced vitamin D3 to\u2019program\u2019T cell attraction to the epidermal chemokine CCL27. Nat. Immunol. 8, 285\u2013293 (2007).","journal-title":"Nat. Immunol."},{"key":"267_CR9","doi-asserted-by":"publisher","first-page":"35039","DOI":"10.1074\/jbc.M113.479113","volume":"288","author":"S Rajagopal","year":"2013","unstructured":"Rajagopal, S. et al. Biased agonism as a mechanism for differential signaling by chemokine receptors. J. Biol. Chem. 288, 35039\u201335048 (2013).","journal-title":"J. Biol. Chem."},{"key":"267_CR10","doi-asserted-by":"publisher","first-page":"3396","DOI":"10.1016\/j.bmc.2016.05.031","volume":"24","author":"B Costa","year":"2016","unstructured":"Costa, B. et al. Synthetic sulfoglycolipids targeting the serine\u2013threonine protein kinase Akt. Bioorg. Med. Chem. 24, 3396\u20133405 (2016).","journal-title":"Bioorg. Med. Chem."},{"key":"267_CR11","doi-asserted-by":"publisher","first-page":"5723","DOI":"10.4049\/jimmunol.1001612","volume":"185","author":"Y Jin","year":"2010","unstructured":"Jin, Y., Xia, M., Sun, A., Saylor, C. M. & Xiong, N. CCR10 is important for the development of skin-specific \u03b3\u03b4T cells by regulating their migration and location. J. Immunol. 185, 5723\u20135731 (2010).","journal-title":"J. Immunol."},{"key":"267_CR12","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1136\/gut.2005.064477","volume":"54","author":"G Nowak","year":"2005","unstructured":"Nowak, G. et al. Identification of expandable human hepatic progenitors which differentiate into mature hepatic cells in vivo. Gut 54, 972\u2013979 (2005).","journal-title":"Gut"},{"key":"267_CR13","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1128\/MCB.00908-15","volume":"36","author":"B He","year":"2016","unstructured":"He, B., Cruz-Topete, D., Oakley, R. H., Xiao, X. & Cidlowski, J. A. Human glucocorticoid receptor \u03b2 regulates gluconeogenesis and inflammation in mouse liver. Mol. Cell. Biol. 36, 714\u2013730 (2016).","journal-title":"Mol. Cell. Biol."},{"key":"267_CR14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12931-015-0231-5","volume":"16","author":"F Daubeuf","year":"2015","unstructured":"Daubeuf, F., Jung, F., Douglas, G. J., Chevalier, E. & Frossard, N. Protective effect of a protein epitope mimetic CCR10 antagonist, POL7085, in a model of allergic eosinophilic airway inflammation. Respir. Res. 16, 77 (2015).","journal-title":"Respir. Res."},{"key":"267_CR15","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/978-1-60761-688-7_3","volume":"640","author":"EL LeCluyse","year":"2010","unstructured":"LeCluyse, E. L. & Alexandre, E. Isolation and culture of primary hepatocytes from resected human liver tissue. Hepatocytes Methods Protoc. 640, 57\u201382 (2010).","journal-title":"Hepatocytes Methods Protoc."},{"key":"267_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-6-169","volume":"6","author":"LA Gon\u00e7alves","year":"2007","unstructured":"Gon\u00e7alves, L. A., Vig\u00e1rio, A. M. & Penha-Gon\u00e7alves, C. Improved isolation of murine hepatocytes for in vitro malaria liver stage studies. Malar. J. 6, 169 (2007).","journal-title":"Malar. J."},{"key":"267_CR17","doi-asserted-by":"crossref","first-page":"6576","DOI":"10.18632\/oncotarget.2134","volume":"5","author":"L Chen","year":"2014","unstructured":"Chen, L. et al. Upregulation of chemokine receptor CCR10 is essential for glioma proliferation, invasion and patient survival. Oncotarget 5, 6576\u20136583 (2014).","journal-title":"Oncotarget"},{"key":"267_CR18","doi-asserted-by":"crossref","first-page":"75763","DOI":"10.18632\/oncotarget.12409","volume":"7","author":"L Ren","year":"2016","unstructured":"Ren, L. et al. Hypoxia-induced CCL28 promotes recruitment of regulatory T cells and tumor growth in liver cancer. Oncotarget 7, 75763 (2016).","journal-title":"Oncotarget"},{"key":"267_CR19","doi-asserted-by":"publisher","first-page":"e57231","DOI":"10.1371\/journal.pone.0057231","volume":"8","author":"J Chu","year":"2013","unstructured":"Chu, J. et al. Apelin ameliorates TNF-\u03b1-induced reduction of glycogen synthesis in the hepatocytes through G protein-coupled receptor APJ. PLoS. One. 8, e57231 (2013).","journal-title":"PLoS. One."},{"key":"267_CR20","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jcyt.2012.11.006","volume":"15","author":"V Alexeev","year":"2013","unstructured":"Alexeev, V., Donahue, A., Uitto, J. & Igoucheva, O. Analysis of chemotactic molecules in bone marrow-derived mesenchymal stem cells and the skin: Ccl27-Ccr10 axis as a basis for targeting to cutaneous tissues. Cytotherapy 15, 171\u2013184. e1 (2013). 184. e171.","journal-title":"Cytotherapy"},{"key":"267_CR21","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1038\/cdd.2015.46","volume":"22","author":"A Wree","year":"2015","unstructured":"Wree, A. et al. Hepatocyte-specific Bid depletion reduces tumor development by suppressing inflammation-related compensatory proliferation. Cell Death & Differ. 22, 1985\u20131994 (2015).","journal-title":"Cell Death & Differ."},{"key":"267_CR22","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.ccell.2016.03.020","volume":"29","author":"J Fortin","year":"2016","unstructured":"Fortin, J. & Mak, T. W. Targeting PI3K Signaling in Cancer: A Cautionary Tale of Two AKTs. Cancer Cell. 29, 429\u2013431 (2016).","journal-title":"Cancer Cell."},{"key":"267_CR23","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.jhep.2011.09.020","volume":"56","author":"B Sun","year":"2012","unstructured":"Sun, B. & Karin, M. Obesity, inflammation, and liver cancer. J. Hepatol. 56, 704\u2013713 (2012).","journal-title":"J. Hepatol."},{"key":"267_CR24","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1002\/hep.25674","volume":"56","author":"JK Stauffer","year":"2012","unstructured":"Stauffer, J. K., Scarzello, A. J., Jiang, Q. & Wiltrout, R. H. Chronic inflammation, immune escape, and oncogenesis in the liver: a unique neighborhood for novel intersections. Hepatology 56, 1567\u20131574 (2012).","journal-title":"Hepatology"},{"key":"267_CR25","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.4254\/wjh.v7.i22.2384","volume":"7","author":"RB Perumpail","year":"2015","unstructured":"Perumpail, R. B., Liu, A., Wong, R. J., Ahmed, A. & Harrison, S. A. Pathogenesis of hepatocarcinogenesis in non-cirrhotic nonalcoholic fatty liver disease: Potential mechanistic pathways. World J. Hepatol. 7, 2384 (2015).","journal-title":"World J. Hepatol."},{"key":"267_CR26","doi-asserted-by":"crossref","unstructured":"Stickel, F. Alcoholic cirrhosis and hepatocellular carcinoma. Biological Basis of Alcohol-Induced Cancer 113\u2013130 (Springer, 2015).","DOI":"10.1007\/978-3-319-09614-8_7"},{"key":"267_CR27","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1146\/annurev-pathol-012414-040323","volume":"10","author":"MV Lin","year":"2015","unstructured":"Lin, M. V., King, L. Y. & Chung, R. T. Hepatitis C virus-associated cancer. Annu. Rev. Pathol. Mech. Dis. 10, 345\u2013370 (2015).","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"267_CR28","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.ejca.2006.01.043","volume":"42","author":"O Simonetti","year":"2006","unstructured":"Simonetti, O. et al. Potential role of CCL27 and CCR10 expression in melanoma progression and immune escape. Eur. J. Cancer 42, 1181\u20131187 (2006).","journal-title":"Eur. J. Cancer"},{"key":"267_CR29","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1182\/blood.V114.22.3243.3243","volume":"114","author":"DM Miller","year":"2009","unstructured":"Miller, D. M., Yoda, A., Yoda, Y. & Weinstock, D. M. Mechanisms of CRLF2 rearrangement with IGH and P2RY8 in B-cell acute lymphoblastic leukemia. Blood 114, 3243\u20133243 (2009).","journal-title":"Blood"},{"key":"267_CR30","doi-asserted-by":"publisher","first-page":"e60185","DOI":"10.1371\/journal.pone.0060185","volume":"8","author":"MW Ali","year":"2013","unstructured":"Ali, M. W. et al. Transcriptional suppression, DNA methylation, and histone deacetylation of the regulator of G-protein signaling 10 (RGS10) gene in ovarian cancer cells. PLoS. ONE. 8, e60185 (2013).","journal-title":"PLoS. ONE."},{"key":"267_CR31","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ccr.2014.07.001","volume":"26","author":"H Nakagawa","year":"2014","unstructured":"Nakagawa, H. et al. ER stress cooperates with hypernutrition to trigger TNF-dependent spontaneous HCC development. Cancer Cell. 26, 331\u2013343 (2014).","journal-title":"Cancer Cell."},{"key":"267_CR32","volume-title":"Role of CCR10 in Progression and Metastasis of Malignant Melanoma","author":"C Schneider","year":"2016","unstructured":"Schneider, C. Role of CCR10 in Progression and Metastasis of Malignant Melanoma. (Heinrich-Heine-Universit\u00e4t, D\u00fcsseldorf, 2016)."},{"key":"267_CR33","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1002\/hep.24516","volume":"54","author":"W Qiu","year":"2011","unstructured":"Qiu, W. et al. PUMA\u2013mediated apoptosis drives chemical hepatocarcinogenesis in mice. Hepatology 54, 1249\u20131258 (2011).","journal-title":"Hepatology"},{"key":"267_CR34","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/cncr.20774","volume":"103","author":"K Nakanishi","year":"2005","unstructured":"Nakanishi, K., Sakamoto, M., Yamasaki, S., Todo, S. & Hirohashi, S. Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma. Cancer 103, 307\u2013312 (2005).","journal-title":"Cancer"},{"key":"267_CR35","doi-asserted-by":"publisher","first-page":"593","DOI":"10.4049\/jimmunol.177.1.593","volume":"177","author":"B Eksteen","year":"2006","unstructured":"Eksteen, B. et al. Epithelial inflammation is associated with CCL28 production and the recruitment of regulatory T cells expressing CCR10. J. Immunol. 177, 593\u2013603 (2006).","journal-title":"J. Immunol."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0267-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0267-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0267-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T11:46:17Z","timestamp":1671536777000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0267-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,14]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,2]]}},"alternative-id":["267"],"URL":"https:\/\/doi.org\/10.1038\/s41419-018-0267-9","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,14]]},"assertion":[{"value":"20 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The clinical protocols of this study were approved by the Ethics Committee of the Second Affiliated Hospital of Nanchang University (Nanchang, China) and the Ethics Committee of Renji Hospital (Shanghai Jiao Tong University School of Medicine, Shanghai, China). All animal procedures were approved by the Animal Care and Use Committee at Renji Hospital (Shanghai Jiao Tong University School of Medicine).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from each participant prior to inclusion in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"232"}}